Nevro Corp. (NVRO)
NYSE NYSE Primary 
Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock?
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 results amid a weak SCS market.
Nevro Q4 Earnings & Revenues Beat Estimates, Gross Margin Down
NVRO's fourth-quarter earnings surpass the Zacks Consensus Estimate, while worldwide revenues decline year over year. The company continues to incur losses at the operating level.
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates
Nevro (NVRO) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to loss of $0.15 per share a year ago.
Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?
Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical Inks $250M Deal to Acquire Nevro: Stock to Gain?
GMED is set to acquire all shares of Nevro in an all-cash transaction, unlocking new growth opportunities.
Nevro (NVRO) Upgraded to Buy: What Does It Mean for the Stock?
Nevro (NVRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Nevro (NVRO) Soars 13.9%: Is Further Upside Left in the Stock?
Nevro (NVRO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Here's Why you Should Add Nevro Stock to Your Portfolio Now
NVRO continues to gain due to its business expansion into the SI joint fusion market and optimistic 2024 preliminary results amid a weak SCS market.
Nevro Stock Falls Despite Q4 Sales Beat on Strong SCS Demand
NVRO's preliminary fourth-quarter revenues showcase decline in worldwide and U.S. revenues.
What Makes Nevro (NVRO) a New Buy Stock
Nevro (NVRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why you Should Retain Nevro Stock in Your Portfolio Now
NVRO's continued technological innovations and business diversification plans raise optimism about the stock.
